查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1848666

介入放射學產品市場​​（按產品類型、應用、最終用戶和分銷管道）—全球預測 2025-2032

Interventional Radiology Products Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年介入放射學產品市場​​將成長至 198.8 億美元，複合年成長率為 6.60%。

主要市場統計數據
基準年2024年 119.2億美元
預計2025年 127億美元
預測年份：2032年 198.8億美元
複合年成長率（%） 6.60%

關於設備創新、臨床需求和不斷變化的護理環境如何重塑全球介入性放射學生態系統的權威介紹。

介入放射學在臨床需求、設備創新和醫療體系轉型的交會中不斷發展。由於成像、能量傳輸和栓塞化學技術的進步，微創手術如今能夠治療更廣泛的病症。臨床醫生越來越青睞有針對性的干涉措施，以降低手術併發症發生率並縮短恢復時間，這重新定義了導管室和混合手術室對各種設備的需求。

本產品涵蓋多種產品，包括熱消融平台、血管成形術用氣球、導管、栓塞劑、栓塞彈簧圈、導管導引線、血管閉合系統和支架技術。在這些類別中，微波和射頻消融術、液體和顆粒栓塞劑以及頸動脈和周邊支架設計等微專業技術創造了獨特的臨床價值提案。應用範圍涵蓋神經血管手術（包括動脈瘤管理和中風血栓切除術）、腫瘤介入（包括經動脈化療栓塞和腫瘤切除）、疼痛管理技術以及各種血管介入治療。

最終用戶範圍廣泛，從醫院到門診手術中心再到診所，每個用戶都有其獨特的手術量、購買行為和固定設備限制。通路，無論是依賴直銷模式或分銷商網路，都會進一步影響產品採用曲線。總而言之，這些因素構成了以下分析的基礎，並為設備創新、向護理環境的過渡以及商業化策略如何決定競爭優勢和臨床影響奠定了基礎。

影像引導創新、門診病人轉變、數位整合和供應鏈彈性將如何改變臨床應用和商業策略

一些變革性的變化正在發生，它們正在重新定義介入放射學的格局，並改變產品開發和商業化的軌跡。首先，影像導引和導航系統的成熟提高了手術的精確度，使得更小的設備能夠更安全地治療更複雜的解剖結構。同時，能量傳遞方式和栓塞材料也日益複雜，支持從一次性器械轉向整合影像、消融和栓塞功能於一體的一體化治療平台的轉變。

隨著手術流程向門診病人和門診環境的轉變，對緊湊、經濟高效的系統和精簡工作流程的需求正在加速成長。這種轉變與最終用戶的購買偏好和資本配置相互影響，迫使製造商重新思考產品外形規格和服務模式。同時，包括程序分析和設備連接在內的數位增強技術正逐漸成為長期臨床醫生參與和上市後監測的差異化因素。

供應鏈彈性和監管預期也在改變。製造商正在投資本地製造和品質體系，以降低中斷風險，而醫療保健系統則要求更有力的臨床效益和成本效益證據。這些變化既帶來了限制，也帶來了機會：縮短了那些展現出明確價值的解決方案的採用時間，同時也增加了缺乏差異化臨床優勢的商品化產品的門檻。

評估累積關稅變化如何影響介入設備價值鏈中的區域製造策略、定價壓力和採購行為

近期的關稅變化對介入器械價值鏈產生了累積影響，促使製造商和採購商重新評估其採購和成本結構。不斷上升的關稅和貿易摩擦推高了進口零件和成品的到岸成本，迫使製造商重新評估其供應商網路、材料選擇和區域製造佈局。因此，企業面臨策略選擇：消化更高的單位成本，重新設計產品以適應替代零件，或將生產轉移到更靠近終端市場的地方。

這些壓力也會波及到分銷模式。由於醫院和門診中心會嚴格審查採購財務狀況，直銷機構可能面臨利潤壓縮和採購週期延長的問題，而分銷商主導的管道則可能面臨庫存重新定價和合約重新談判的困境。臨床醫生和採購團隊將優先考慮能夠縮短手術時間並降低整體事件成本的多功能平台和解決方案，從而以已證實的臨床和經濟效益抵消不斷上漲的設備價格。

對此，製造商可以採取適應性定價策略，達成長期供應協議，並尋求區域製造夥伴關係，以穩定其成本結構。同時，更有力的臨床證據和結果記錄將成為在採購審議中維護定價和證明產品選擇合理性的重要工具。總而言之，這些因應措施將為介入醫療設備創造一個更具彈性、區域均衡的製造和商業模式。

關鍵細分洞察概述了產品模式、臨床用途、醫療保健環境和分銷動態如何相互影響以形成採用和商業化

詳細的細分揭示了臨床需求和機會在產品類型、應用、最終用戶通路和通路之間的交匯點。微波和射頻系統提供獨特的消融特性，影響腫瘤消融通訊協定；而血管成形術球囊、導管、導管導引線和支架則滿足了機械再灌注的需求。栓塞療法包括能夠遠距離穿透的液體栓塞劑和提供可控閉塞的顆粒栓塞劑；支架設計也分為頸動脈保護型和周邊支架型。

腫瘤治療採用經動脈化療栓塞術和腫瘤消融術，這依賴栓塞劑和能源來源的協同作用。疼痛管理程序需要精準的病灶定位，盡量減少附帶組織損傷。血管介入治療涵蓋多種急性和慢性適應症，這些適應症會影響器械規格和輔助性治療。

最終使用者的購買行為和治療環境各不相同：醫院通常偏好提供全方位服務支援的綜合平台；門診手術中心尋求緊湊、經濟高效且最佳化吞吐量的系統；診所則優先考慮能夠當天完成手術且結果可預測的設備。經銷商的選擇（直銷還是分銷商）會影響售後服務預期、培訓承諾和庫存管理，進而影響製造商的商業營運和培訓投資結構。

將臨床需求、監管複雜性和製造重點與全球主要市場的可行商業化路徑連結起來的區域情報

區域動態對設備設計、監管策略和商業化計畫有著強大的影響。在美洲，醫療系統越來越注重基於價值的醫療服務以及向門診病人的轉型，這推動了對成本效益高、手術吞吐量高的醫療設備的需求。大型醫療系統也重視包括培訓和長期服務協議在內的採購夥伴關係。

在歐洲、中東和非洲，法規環境和報銷架構呈現一系列要求，這些要求重視臨床證據和互通性。採購週期可能更長且更加分散，但對於能夠滿足多樣化臨床需求、同時符合區域標準和本地製造要求的設備而言，仍有機會。此外，一些市場的醫療保健能力限制正在加速採用微創手術，以減少住院時間和加護治療的使用率。

亞太地區的特點是基礎設施投資快速成長、治療量不斷擴大以及中階對先進療法的需求不斷成長。本地製造能力和夥伴關係通常決定市場准入，而定價和服務模式的靈活性則可能成為關鍵的差異化因素。在整個地區，臨床證據、監管檔案和供應鏈策略的實際本地化對於將臨床興趣轉化為持續應用至關重要。

公司和競爭情報表明平台策略、夥伴關係和證據主導的商業化將決定介入設備市場的永續優勢

企業策略正日益轉向平台整合、集中研發投入和選擇性夥伴關係，以加速臨床應用。主要企業優先考慮整合影像、治療交付和資訊服務的跨職能產品組合，而新興企業則瞄準技術差異化與臨床需求交匯處的利基市場。設備原始設備製造商 (OEM) 和軟體供應商之間的合作正在不斷擴展，創造出支援手術規劃、術中指導和上市後結果追蹤的互聯解決方案。

雖然併購仍是取得互補技術和基本客群的戰術性途徑，但收購者更重視與現有服務模式和監管框架的契合。製造外包和策略外包可以降低資本強度，但需要嚴格的品質監督以保持設備的可靠性。早期投資於臨床證據產生和現場培訓的公司往往能夠獲得持續的臨床醫生忠誠度並獲得順利的採購核准。

從商業性角度來看，那些根據手術時間、住院時間和重複干預次數的減少情況調整定價模式的公司，將創造更強大的價值提案。此外，隨著醫療服務從傳統醫院轉移，那些為門診和診所環境建立可擴展支援基礎設施的公司，也將獲得成長。最終，一家公司在研發優先順序、通路管理和證據開發方面的敏捷性將決定其在這個不斷變化的市場中的競爭地位。

為產業領導者提供可行的策略建議，以增強供應彈性、加速門診病人採用並將主導臨床價值收益

產業領導者應優先考慮一系列切實可行的行動，以平衡短期韌性與長期成長。首先，實現製造和供應鏈佈局多元化，以降低貿易中斷帶來的風險，並滿足特定地區的監管要求。此策略應包括關鍵零件的雙重採購、高風險產品的選擇性近岸外包以及供應商風險分擔安排，以保障供應的連續性。

其次，我們將投入資金，產生能夠明確將醫療設備性能與患者治療結果以及整個治療過程的經濟效益聯繫起來的臨床證據。高品質的註冊登記、務實的臨床試驗以及強大的上市後監測，將促進更有效的報銷對話，並支持其在價值驅動型醫療保健系統中的應用。第三，為了因應門診病人移動化的趨勢，我們將重組產品系列，開發緊湊型、輕服務平台，在維持臨床有效性的同時，減輕門診中心和診所的資本和營運負擔。

第四，我們將強化通路策略，根據當地市場實際情況調整直銷和分銷模式，並確保培訓和服務能力符合最終用戶的期望。第五，我們將利用數位化工具進行程序分析、遠端培訓和設備連接，以深化臨床醫生的參與度並產生經常性業務收益。最後，我們將採用自適應定價和合約框架，使商業性條款與已證實的臨床價值保持一致，從而在價格敏感的環境中實現更可預測的採購結果。

由臨床醫生主導的透明調查方法，結合主要相關人員的參與、次要證據的綜合和嚴格的三角測量來檢驗策略見解

調查方法結合了初步定性研究、二手資料整合和嚴格的三角檢驗，以確保研究結果基於臨床現實和商業性實踐。主要輸入包括與執業干預醫師、採購主管、醫院管理人員、門診手術中心營運人員和經銷商合作夥伴進行結構化訪談，以掌握關於臨床需求、採購促進因素和服務期望的第一手觀點。專家小組和臨床醫生顧問委員會負責檢驗臨床趨勢和設備性能特徵。

二級研究整合了同行評審文獻、臨床註冊、監管申報和產品技術文檔，以繪製技術屬性和過往應用軌跡。在可取得的情況下，程式編碼趨勢和已發表的結局資料可用於臨床路徑評估，而供應鏈流程和貿易模式分析可用於製造和分銷風險評估。數據透過多個資訊來源進行交叉檢驗，並與主要相關人員的回饋進行交叉引用，以減少偏差。

此細分框架系統地應用於產品、應用、最終用戶和分銷等維度，以識別臨床需求與商業性可行性之間的整合領域。限制和假設均清楚記錄，並進行敏感度檢驗，以檢驗不同情境如何影響策略意義。隨著新的臨床證據和政策發展的出現，鼓勵相關人員參與，不斷改善見解。

整合臨床、商業和管理向量的明確結論，以確定不斷發展的介入治療的勝利策略

這份全面的分析報告強調，市場正處於動態轉型之中，其特徵是技術日益成熟，醫療環境向低成本轉型，以及對彈性商業和製造模式的需求。能夠平衡手術效果和營運效率的設備創新，很可能會引起臨床醫生和採購團隊的濃厚興趣。同時，地緣政治和貿易因素也推動了多元化供應鏈和在地化市場策略的重要性。

成功的企業將在於能夠將可靠的臨床證據與適應性強的產品平台相結合，提供令人信服的整體護理成本 (TCO) 故事，並執行嚴謹的管道和定價策略。與臨床醫生、醫療系統和經銷商建立值得信賴的夥伴關係，仍將是加速產品採用和減少採購摩擦的關鍵差異化因素。隨著臨床路徑的演變以及新型能量模式和栓塞化學療法的日益普及，持續投資於上市後數據收集、培訓和數位化準備將保持競爭優勢。

最終，臨床需求、監管預期和商業性敏捷性的相互作用將決定未來發展方向。相關人員將研發重點與成熟的醫療體系價值觀結合，並投資於營運韌性，將最有可能實現持久的臨床和商業性影響。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合基於人工智慧的影像引導系統，提供即時程式決策支持
  • 開發可生物吸收的栓塞材料，最大限度地減少長期血管阻塞
  • 採用緊湊型 C 臂成像系統，提升移動套件的便攜性
  • 利用微波和雷射技術擴展微創腫瘤切除設備
  • 整合先進的 3D 列印技術，用於患者特定的血管模型和設備規劃
  • 由於安全法規更加嚴格，對輻射劑量減少技術的需求激增
  • 用於治療動靜脈畸形 (AVM) 的聚合性和非黏附性液體栓塞系統的快速成長
  • 新興機器人導管導航平台提高了複雜干預的精確度

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 介入放射學產品市場​​（依產品類型）

  • 消融設備
    • 微波消融裝置
    • 射頻消融術裝置
  • 血管成形術用氣球
  • 導管
  • 栓塞劑
    • 液體栓子
    • 顆粒栓塞
  • 栓塞線圈
  • 導管導引線
  • 血管閉合裝置
  • 血管支架
    • 頸動脈支架
    • 周邊血管支架

9. 介入性放射學產品市場​​（按應用）

  • 神經介入
    • 動脈瘤栓塞
    • 中風血栓切除術
  • 腫瘤干預
    • 經動脈化療栓塞術
    • 腫瘤消融
      • 冷凍療法
      • 微波消融裝置
      • 射頻消融術裝置
  • 疼痛管理
  • 血管介入

第 10 章介入放射學產品市場​​（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院

第 11 章介入放射學產品市場​​（依分銷通路）

  • 直銷
  • 經銷商銷售

12. 介入性放射學產品市場​​（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章介入放射學產品市場​​（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。 介入性放射學產品市場​​（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Boston Scientific Corporation
    • Medtronic plc
    • Siemens Healthineers AG
    • GE HealthCare Technologies, Inc.
    • Koninklijke Philips NV
    • Terumo Corporation
    • Cook Medical LLC
    • Cardinal Health, Inc.
    • Guerbet SA
    • Merit Medical Systems, Inc.
Product Code: MRR-46132FF7A845

The Interventional Radiology Products Market is projected to grow by USD 19.88 billion at a CAGR of 6.60% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 11.92 billion
Estimated Year [2025] USD 12.70 billion
Forecast Year [2032] USD 19.88 billion
CAGR (%) 6.60%

An authoritative introduction to how device innovation, clinical demand, and care setting shifts are reshaping the interventional radiology ecosystem globally

Interventional radiology continues to evolve at the intersection of clinical need, device innovation, and health system transformation. Minimally invasive techniques now address a broader range of pathologies, driven by advances in imaging, energy delivery, and embolic chemistries. Clinicians increasingly prefer targeted interventions that reduce procedural morbidity and shorten recovery time, which in turn redefines demand across the spectrum of devices used in the catheterization laboratory and hybrid suites.

This narrative encompasses a diverse product landscape that includes thermal ablation platforms, angioplasty balloons, catheters, embolic agents, embolization coils, guidewires, vascular closure systems, and stent technologies. Within these categories, sub-specialized modalities such as microwave and radiofrequency ablation, liquid and particulate embolics, and carotid versus peripheral stent designs create distinct clinical value propositions. Applications span neurovascular procedures through aneurysm management and stroke thrombectomy, oncology interventions via transarterial chemoembolization and tumor ablation, pain management techniques, and a broad range of vascular interventions.

End users vary from hospitals to ambulatory surgical centers and clinics, each presenting unique procedural volumes, purchasing behaviors, and capital equipment constraints. Distribution pathways that rely on either direct sales models or distributor networks further shape product adoption curves. Taken together, these elements form the foundation for the analysis that follows, setting context for how device innovation, care setting migration, and commercialization strategies will determine competitive advantage and clinical impact.

How image-guided innovation, outpatient migration, digital integration, and supply chain resilience are collectively transforming clinical adoption and commercial strategy

Several transformative shifts are redefining the interventional radiology landscape and altering the trajectory of product development and commercialization. First, the maturation of image guidance and navigation systems has elevated procedural precision, enabling smaller devices and more complex anatomies to be treated safely. Concurrently, energy delivery modalities and embolic materials are becoming more sophisticated, which supports a movement from single-use instruments toward integrated therapy platforms that combine imaging, ablation, and embolization capabilities.

The migration of procedures to outpatient settings and ambulatory surgical environments is accelerating demand for compact, cost-efficient systems and streamlined workflows. This transition interacts with end-user purchasing preferences and capital allocation, prompting manufacturers to rethink product form factors and service models. At the same time, digital augmentation, including procedure analytics and device connectivity, is emerging as a differentiator for long-term clinician engagement and post-market surveillance.

Supply chain resilience and regulatory expectations are also shifting. Manufacturers are investing in regional manufacturing and quality systems to reduce exposure to disruptions, and health systems are demanding stronger evidence of clinical benefit and cost-effectiveness. These changes create both constraints and opportunities: they compress time-to-adoption for solutions that demonstrate clear value while increasing barriers for commoditized products without differentiated clinical advantage.

Assessing how cumulative tariff shifts have catalyzed regional manufacturing strategies, pricing pressure, and procurement behaviors across the interventional device value chain

Recent tariff dynamics have exerted a cumulative impact on the interventional device value chain, prompting manufacturers and purchasers to reassess sourcing and cost structures. Increased duties and trade frictions raise the landed cost of imported components and finished products, which places pressure on manufacturers to re-evaluate supplier networks, materials choice, and regional manufacturing footprints. As a result, organizations face a strategic choice between absorbing higher unit costs, re-engineering products for alternative components, or shifting production closer to end markets.

These pressures ripple through distribution models: direct sales organizations may confront margin compression and longer procurement cycles as hospitals and ambulatory centers scrutinize purchased capital, while distributor-led channels contend with inventory re-pricing and contractual renegotiations. Clinicians and procurement teams respond by prioritizing multi-functional platforms and solutions that reduce procedure time and overall episode cost, thereby offsetting device price inflation with demonstrable clinical and economic benefits.

In response, manufacturers can adopt adaptive pricing strategies, secure longer-term supply agreements, and pursue localized manufacturing partnerships to stabilize cost structures. Meanwhile, stronger clinical evidence and outcomes documentation become essential tools to defend pricing and justify product selection during procurement deliberations. Collectively, these responses shape a more resilient and regionally balanced manufacturing and commercial model for interventional devices.

Key segmentation insights outlining how product modalities, clinical applications, care settings, and distribution dynamics intersect to shape adoption and commercialization

Detailed segmentation reveals where clinical demand and commercial opportunity converge across product types, applications, end-user channels, and distribution pathways. From a product perspective, thermal ablation devices coexist with a broad array of vascular tools: microwave and radiofrequency systems deliver distinct ablative profiles that influence tumor ablation protocols, while angioplasty balloons, catheters, guidewires, and stents address mechanical revascularization needs. Embolic therapies vary between liquid embolics that enable distal penetration and particulate agents that provide calibrated occlusion, and stent designs differentiate between carotid protection and peripheral vessel scaffolding.

Application-driven dynamics show that neuro interventions such as aneurysm embolization and stroke thrombectomy require ultra-high reliability and rapid device availability, whereas oncology interventions leverage both transarterial chemoembolization and tumor ablation approaches that depend on synergy between embolic materials and energy sources. Pain management procedures demand precise lesion targeting with minimal collateral tissue damage, and vascular interventions span a wide spectrum of acute and chronic indications that influence device specifications and adjunctive therapies.

End users exhibit divergent purchasing behaviors and procedural settings. Hospitals typically favor comprehensive platforms with full-service support, ambulatory surgical centers seek compact and cost-effective systems optimized for throughput, and clinics focus on devices that enable same-day procedures with predictable outcomes. Distribution choices between direct sales and distributor networks affect post-sale service expectations, training commitments, and inventory management, shaping how manufacturers structure commercial operations and training investments.

Regional intelligence that connects clinical demand, regulatory complexity, and manufacturing priorities to actionable commercialization pathways across key global markets

Regional dynamics exert a powerful influence on device design, regulatory strategy, and commercial planning. In the Americas, health systems are increasingly focused on value-based care and outpatient migration, driving demand for devices that demonstrate cost-efficiency and procedural throughput gains. The payer landscape encourages rigorous outcomes data to support inclusion in care pathways, and the scale of large health systems emphasizes purchasing partnerships that include training and long-term service agreements.

Across Europe, Middle East & Africa, the regulatory environment and reimbursement architectures present a mosaic of requirements that reward clinical evidence and interoperability. Procurement cycles can be longer and more fragmented, but opportunities exist for devices that meet diverse clinical needs while conforming to regional standards and local manufacturing expectations. In addition, healthcare capacity constraints in some markets accelerate adoption of less invasive therapies that reduce hospital stay and intensive care utilization.

Asia-Pacific is characterized by rapid infrastructure investment, expanding procedural volumes, and a growing middle-class demand for advanced therapies. Local manufacturing capabilities and partnerships often determine market access, and agility in pricing and service models can be a decisive differentiator. Across all regions, pragmatic localization of clinical evidence, regulatory dossiers, and supply chain strategies remains essential to converting clinical interest into sustained adoption.

Corporate and competitive intelligence showing how platform strategies, partnerships, and evidence-led commercialization determine sustainable advantage in interventional device markets

Corporate strategies are increasingly centered on platform consolidation, focused R&D investment, and selective partnerships that accelerate time to clinical adoption. Leading organizations prioritize cross-functional portfolios that integrate imaging, therapy delivery, and data services, while emerging companies target niche indications where technical differentiation and clinical need intersect. Collaboration between device OEMs and software providers is expanding, yielding connected solutions that support procedural planning, intra-procedural guidance, and post-market outcomes tracking.

Mergers and acquisitions remain a tactical route to acquire complementary technologies and receptive customer bases, but acquirers emphasize fit with existing service models and regulatory footprints. Contract manufacturing and strategic outsourcing reduce capital intensity but require rigorous quality oversight to maintain device reliability. Companies that invest early in clinical evidence generation and in-field training resources tend to secure durable clinician loyalty and smoother procurement approvals.

From a commercial perspective, firms that align pricing models with documented reductions in procedure time, hospital stay, or repeat interventions create stronger value propositions. Additionally, organizations that build scalable support infrastructures for ambulatory settings and clinics capture growth as care migrates out of traditional hospitals. Ultimately, corporate agility in R&D prioritization, channel management, and evidence development determines competitive positioning in this evolving marketplace.

Actionable strategic recommendations for industry leaders to build supply resilience, accelerate outpatient adoption, and monetize evidence-driven clinical value

Industry leaders should prioritize a set of pragmatic actions that balance short-term resilience with long-term growth. First, diversify manufacturing and supply chain footprints to reduce exposure to trade disruptions and to accommodate localized regulatory requirements. This strategy should include dual sourcing of critical components, selective nearshoring for high-risk items, and collaborative supplier risk-sharing arrangements to protect continuity of supply.

Second, invest in clinical evidence generation that clearly ties device performance to patient outcomes and total episode-of-care economics. High-quality registries, pragmatic clinical trials, and strong post-market surveillance enable more effective reimbursement conversations and support adoption in value-oriented health systems. Third, reconfigure product portfolios to address the outpatient migration trend by developing compact, service-light platforms that maintain clinical efficacy while reducing capital and operational burden for ambulatory centers and clinics.

Fourth, strengthen channel strategies by calibrating direct sales and distributor models to regional market realities, ensuring training and service capabilities match end-user expectations. Fifth, leverage digital tools for procedure analytics, remote training, and device connectivity to deepen clinician engagement and to create recurring service revenue. Finally, adopt adaptive pricing and contracting frameworks that align commercial terms with demonstrated clinical value, enabling more predictable procurement outcomes in price-sensitive environments.

A transparent, clinician-anchored methodology blending primary stakeholder engagement, secondary evidence synthesis, and rigorous triangulation to validate strategic insights

The research methodology combines primary qualitative engagement, secondary data integration, and rigorous triangulation to ensure findings are grounded in both clinical reality and commercial practice. Primary inputs include structured interviews with practicing interventionalists, procurement leaders, hospital administrators, ambulatory surgical center operators, and distributor partners to capture firsthand perspectives on clinical needs, purchasing drivers, and service expectations. Expert panels and clinician advisory boards provide validation of clinical trends and device performance characteristics.

Secondary research synthesizes peer-reviewed literature, clinical registries, regulatory filings, and product technical documentation to map technology attributes and historical adoption trajectories. Where available, procedure coding trends and published outcomes data inform the assessment of clinical pathways, while analyses of supply chain flows and trade patterns support evaluation of manufacturing and distribution risk. Data are cross-validated through multiple sources and reconciled with primary stakeholder feedback to reduce bias.

The segmentation framework is applied systematically across product, application, end-user, and distribution dimensions to identify areas of convergence between clinical need and commercial feasibility. Limitations and assumptions are documented transparently, and sensitivity checks are performed to test how alternative scenarios affect strategic implications. Ongoing stakeholder engagement is recommended to refine insights as new clinical evidence and policy developments emerge.

A decisive conclusion synthesizing clinical, commercial, and operational vectors that define winning strategies in the evolving landscape of interventional therapies

The collective analysis underscores a market in active transition, characterized by technological refinement, migration of care to lower-cost settings, and a need for resilient commercial and manufacturing models. Device innovation that couples procedural efficacy with operational efficiency will command heightened interest from clinicians and procurement teams alike. At the same time, geopolitical and trade considerations have elevated the importance of diversified supply chains and regionally attuned go-to-market strategies.

Success will favor organizations that combine robust clinical evidence with adaptable product platforms, deliver compelling total cost-of-care narratives, and execute disciplined channel and pricing strategies. Building trusted partnerships with clinicians, health systems, and distributors remains a critical differentiator that accelerates adoption and mitigates procurement friction. As clinical pathways evolve and new energy modalities and embolic chemistries gain traction, continuous investment in post-market data collection, training, and digital enablement will sustain competitive positioning.

Ultimately, the interplay of clinical need, regulatory expectations, and commercial agility defines the path forward. Stakeholders who align R&D priorities with demonstrated health system value and who invest in operational resilience will be best positioned to capture enduring clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-based image guidance systems for real-time procedural decision support
  • 5.2. Development of bioresorbable embolic materials to minimize long-term vessel blockages
  • 5.3. Adoption of compact C-arm imaging systems for enhanced portability in mobile suites
  • 5.4. Expansion of minimally invasive tumor ablation devices using microwave and laser technologies
  • 5.5. Integration of advanced 3D printing for patient-specific vascular phantoms and device planning
  • 5.6. Surge in demand for radiation dose reduction technologies to comply with stricter safety regulations
  • 5.7. Rapid growth of liquid embolic systems incorporating polymerizable and nonadhesive agents for AVM treatment
  • 5.8. Emergence of robotic catheter navigation platforms to improve precision in complex interventions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Interventional Radiology Products Market, by Product Type

  • 8.1. Ablation Devices
    • 8.1.1. Microwave Ablation Devices
    • 8.1.2. Radiofrequency Ablation Devices
  • 8.2. Angioplasty Balloons
  • 8.3. Catheters
  • 8.4. Embolic Agents
    • 8.4.1. Liquid Embolics
    • 8.4.2. Particulate Embolics
  • 8.5. Embolization Coils
  • 8.6. Guidewires
  • 8.7. Vascular Closure Devices
  • 8.8. Vascular Stents
    • 8.8.1. Carotid Stents
    • 8.8.2. Peripheral Vascular Stents

9. Interventional Radiology Products Market, by Application

  • 9.1. Neuro Intervention
    • 9.1.1. Aneurysm Embolization
    • 9.1.2. Stroke Thrombectomy
  • 9.2. Oncology Intervention
    • 9.2.1. Transarterial Chemoembolization
    • 9.2.2. Tumor Ablation
      • 9.2.2.1. Cryoablation
      • 9.2.2.2. Microwave Ablation Devices
      • 9.2.2.3. Radiofrequency Ablation Devices
  • 9.3. Pain Management
  • 9.4. Vascular Intervention

10. Interventional Radiology Products Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Interventional Radiology Products Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales

12. Interventional Radiology Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Interventional Radiology Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Interventional Radiology Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Siemens Healthineers AG
    • 15.3.4. GE HealthCare Technologies, Inc.
    • 15.3.5. Koninklijke Philips N.V.
    • 15.3.6. Terumo Corporation
    • 15.3.7. Cook Medical LLC
    • 15.3.8. Cardinal Health, Inc.
    • 15.3.9. Guerbet S.A.
    • 15.3.10. Merit Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL R